October 27, 2023
Semaglutide (GLP-1 RA) medications are a once-weekly injection prescribed to treat adults with type 2 diabetes
The standard escalation on a plotter The Wegovy (weight management) protocol escalates as follows: 0.25 mg weekly for four weeks, then 0.5 mg for four weeks, then 1.0 mg for four weeks, then 1.7 mg for four weeks, and finally 2.4 mg as the maintenance dose
It competes with dozens of other sources, each with different strengths, weaknesses, and track records
Instead, the company is working with a 503B compounding pharmacy (also known as a 503B manufacturer) producing large batches of these medications
Mounjaro and Wegovy, the most common GLP-1 medications, were approved by the National Institute of Health and Care Excellence (NICE) as weight loss medications in the last few years, but are still only available on the NHS under certain criteria